{"id":"https://openalex.org/W2979020388","doi":"https://doi.org/10.14309/00000434-200809001-01010","title":"Influence of Responder Definition on Placebo Response","display_name":"Influence of Responder Definition on Placebo Response","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2979020388","doi":"https://doi.org/10.14309/00000434-200809001-01010","mag":"2979020388"},"language":"en","primary_location":{"id":"doi:10.14309/00000434-200809001-01010","doi":"https://doi.org/10.14309/00000434-200809001-01010","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-200809001-01010","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027136649","display_name":"William D. Chey","orcid":"https://orcid.org/0000-0002-4584-4026","observed_orcids":["https://orcid.org/0000-0002-4584-4026"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William Chey","raw_affiliation_strings":["University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4210114445","https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022123400","display_name":"Douglas A. Drossman","orcid":"https://orcid.org/0000-0002-8178-0453","observed_orcids":["https://orcid.org/0000-0002-8178-0453"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Drossman","raw_affiliation_strings":["University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4210114445","https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charles Baum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Baum","raw_affiliation_strings":["University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4210114445","https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113738093","display_name":"Ryuji Ueno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryuji Ueno","raw_affiliation_strings":["University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health System, Ann Arbor, MI, UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, Takeda Pharmaceuticals North America, Inc., Deerfield, IL, Sucampo Pharmaceuticals, Inc., Bethesda, MD","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4210114445","https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5027136649"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4210114445","https://openalex.org/I4210140176"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.48946041,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"103","issue":null,"first_page":"S395","last_page":"S396"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12035","display_name":"Pain Management and Placebo Effect","score":0.1006999984383583,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.9079999923706055},{"id":"https://openalex.org/keywords/responder-definition","display_name":"responder definition","score":0.8309999704360962},{"id":"https://openalex.org/keywords/irritable-bowel-syndrome-with-constipation","display_name":"irritable bowel syndrome with constipation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/lubiprostone","display_name":"lubiprostone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/symptom-relief","display_name":"symptom relief","score":0.6399999856948853},{"id":"https://openalex.org/keywords/likert-scale","display_name":"Likert scale","score":0.5799999833106995},{"id":"https://openalex.org/keywords/treatment-response-criteria","display_name":"treatment response criteria","score":0.503000020980835},{"id":"https://openalex.org/keywords/therapeutic-gain","display_name":"therapeutic gain","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C2781093762","wikidata":"https://www.wikidata.org/wiki/Q6695342","display_name":"Lubiprostone","level":4,"score":0.9696812629699707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9400159120559692},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.847342848777771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6128508448600769},{"id":"https://openalex.org/C2781112942","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Constipation","level":2,"score":0.5200281143188477},{"id":"https://openalex.org/C2778271842","wikidata":"https://www.wikidata.org/wiki/Q838966","display_name":"Irritable bowel syndrome","level":2,"score":0.47533583641052246},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4589115381240845},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.45762619376182556},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38448506593704224},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35050690174102783},{"id":"https://openalex.org/C3017955636","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Chronic constipation","level":3,"score":0.136775940656662},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/00000434-200809001-01010","doi":"https://doi.org/10.14309/00000434-200809001-01010","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-200809001-01010","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979028084","https://openalex.org/W2978610849","https://openalex.org/W2088344246","https://openalex.org/W3194946048","https://openalex.org/W1996621414","https://openalex.org/W4316078287","https://openalex.org/W2168787978","https://openalex.org/W2010971619","https://openalex.org/W2978587151","https://openalex.org/W1514209355"],"abstract_inverted_index":{"Purpose:":[0],"Clinical":[1],"trials":[2,51,307],"of":[3,23,42,52,60,71,172,200,236,258,264],"pharmaceutical":[4],"agents":[5],"using":[6,85],"global":[7],"responder":[8,35,61,104,251],"analyses":[9,218],"in":[10,33,46,106,112,134,205,276,308],"patients":[11,44,188,202,309],"with":[12,16,190,230,238,310],"irritable":[13],"bowel":[14],"syndrome":[15],"constipation":[17],"(IBS-C)":[18],"report":[19],"a":[20,86,113,135,196,222,270,277],"wide":[21],"range":[22],"placebo":[24,64,180,194,279],"response":[25,65,183,274,280,291],"rates.":[26,66],"One":[27],"explanation":[28],"may":[29],"be":[30],"the":[31,34,58,75,83,159,179,207,234,250,256,286],"difference":[32],"criteria.":[36],"Methods:":[37],"A":[38],"post-hoc":[39],"pooled":[40],"analysis":[41,115,138],"1071":[43],"enrolled":[45],"2":[47,131,156],"Phase":[48],"III":[49],"placebo-controlled":[50],"lubiprostone":[53,182,191,201,231],"was":[54,232],"performed":[55],"to":[56,79,97,165,193,261],"determine":[57,166],"impact":[59],"definitions":[62,292],"on":[63,285],"Patients":[67],"rated":[68],"their":[69],"relief":[70],"IBS-C":[72,259],"symptoms":[73,257],"over":[74],"past":[76],"week":[77],"compared":[78,192,260],"before":[80],"they":[81],"entered":[82],"study":[84],"7-point":[87],"balanced":[88],"Likert":[89],"Symptom":[90],"Relief":[91],"Scale":[92],"(\u22123":[93],"=":[94,100],"significantly":[95,101,197,254],"worse":[96],"+":[98],"3":[99],"relieved).":[102],"Monthly":[103],"percentages":[105],"each":[107],"treatment":[108,167,273,306],"group":[109],"were":[110,163],"defined":[111],"stringent":[114,137,208,214],"as":[116,139,203,269],"those":[117],"reporting":[118],"\u201c+2-moderately":[119,151],"relieved\u201d":[120,127,143,152,176,268],"for":[121,128,144,153,272],"all":[122,145],"4":[123,146],"weeks":[124,132,147,157],"or":[125,148],"\u201c+3-significantly":[126],"at":[129,149,154],"least":[130,150,155],"and":[133,181,212,242,300],"less":[136,213],"\u201c+1-a":[140,173],"little":[141,174,266,283],"bit":[142,175,267],"within":[158],"month.":[160],"Patient":[161],"outcomes":[162],"reviewed":[164],"effect":[168,284],"differences.":[169],"Results:":[170],"Inclusion":[171,263],"dramatically":[177],"increased":[178],"(Figure).":[184],"Statistical":[185],"comparison":[186],"across":[187,304],"treated":[189],"showed":[195],"greater":[198,278],"percentage":[199],"responders":[204],"both":[206],"(*P":[209],"<":[210,216],"0.0005)":[211],"(**P":[215],"0.03)":[217],"(P":[219],"values":[220],"represent":[221],"combined":[223],"analysis).":[224],"The":[225],"overall":[226,287],"therapeutic":[227,288],"gain":[228],"observed":[229],"primarily":[233],"result":[235],"subjects":[237,243],"stable":[239],"symptoms,":[240],"dropouts":[241],"who":[244],"demonstrated":[245],"symptom":[246],"worsening":[247],"shifting":[248],"into":[249],"group.FigureConclusion:":[252],"Lubiprostone":[253],"improves":[255],"placebo.":[262],"\u201ca":[265],"criterion":[271],"resulted":[275],"but":[281],"had":[282],"gain.":[289],"Treatment":[290],"require":[293],"consideration":[294],"when":[295,301],"evaluating":[296],"individual":[297],"trial":[298],"findings":[299],"making":[302],"comparisons":[303],"clinical":[305],"IBS-C.":[311]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-10-10T00:00:00"}